Stock Spotlight Archives - Page 178 of 389

FridayJul 23, 2021 11:36 am

QualityStocksNewsBreaks – Friendable Inc.’s (FDBL) Fan Pass 2.0 to Blow Artists Away, Build Buzz to Drive Future Growth

Friendable (OTC: FDBL), a mobile technology and marketing company, is set to launch Fan Pass version 2.0 on July 24, the platform’s first anniversary. For almost a year, Fan Pass has been turning the live streaming industry into a place where artists can truly earn revenue on ticketed online concerts, merch sales and on-demand video content. “Even with venues beginning to open around the world, Fan Pass has not lost any momentum — artist sign-ups grow month after month,” reads a recent article. “Commenting on the upcoming release of Fan Pass platform’s version 2.0, CEO Robert A. Rositano, Jr. voiced…

FridayJul 23, 2021 11:12 am

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Poised as Key Innovative Leader at Forefront in Neurology Tech

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, is a recognized leading innovative player in the brain monitoring space. The company continues to be at the forefront of what is next in neurology technology. In a Tech Times feature, Brain Scientific’s Marketing Director Irina Nazarova outlined key brain monitoring trends to watch in 2021, including the fact that brain monitoring is becoming as popular and widespread as monitoring pulse or heart rate. Several potential applications have swelled, and EEG monitoring is no longer a preserve of clinicians and expert neuroscientific researchers. A recent article…

FridayJul 23, 2021 10:52 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Looking to Unlock Additional Value with Russell 2000 Index Inclusion

CNS Pharmaceuticals (NASDAQ: CNSP), a pharmaceutical company enthusiastically pursuing enrollment of about 243 brain cancer patients in a clinical trial designed to analyze the efficacy and safety of its lead drug candidate, was selected to be added to the Russell 2000 Index effective June 25. A subset of the Russell 3000 Index, the Russell 2000 Index is a measure of the performance of the small-cap segment of the U.S. equity market. Per CNS Pharmaceuticals CEO John Climaco, quoted in a recent article, the company was pleased to meet this noteworthy milestone. He said, “As our team continues to drive our…

ThursdayJul 22, 2021 12:30 pm

QualityStocksNewsBreaks – Ideanomics Inc.’s (NASDAQ: IDEX) Accomplished Team Poised to Develop, Commercialize Industry Changing Transportation Solutions

Ideanomics (NASDAQ: IDEX) was pleased to see Dr. Abas Goodarzi, its newly appointed chief scientist and US Hybrid CEO, recognized with the well-deserved Institute of Electrical and Electronics Engineers (“IEEE”) Power Electronics Society (“PELS”) Vehicle and Transportation Systems Achievement Award. Dr. Goodarzi, an industry veteran with 38 years of experience in the electric, hybrid and fuel cell industries, was recognized for his contributions to the advancement of electric powertrains for medium and heavy duty vehicles. A recent article quoted Ideanomics CEO Alf Poor as saying, “He has done, and continues to do, so much to advance the transition to a…

ThursdayJul 22, 2021 12:19 pm

QualityStocksNewsBreaks – FingerMotion Inc. (FNGR) Looks to Be Ahead of Data Insights Curve

FingerMotion (OTCQX: FNGR) is in a position to capitalize on the emerging big data opportunities in China thanks to its newly launched Big Data Insights (Sapientus) division. “FingerMotion believes its future lies in the Sapientus division and a look at the various big data opportunities in China suggests the reasoning behind this belief,” reads a recent article. The government-led digital transformation is expected to expand the big data market in the next few years, and investment opportunities of big data technology in China are projected to grow at a 30% CAGR between 2021 and 2026. “Thanks to a relationship forged…

WednesdayJul 21, 2021 2:00 pm

QualityStocksNewsBreaks – Emaginos Inc. Delivering Customized Education to Each Child

Emaginos, a REG-A public company (please see website if interested in investing) in the business of transforming K-12 public education, is determined to change the public school system. “According to the National Assessment of Education Progress (‘NAEP’) science assessment, only 36% of 4th graders were proficient in science in 2019, with 35% of 8th graders reaching proficiency and significantly fewer — 22% of 12th graders testing at or above a proficient level of science,” reads a recent article. Emaginos is determined to change these types of results, especially given that public school students’ test scores are significantly lower than students…

WednesdayJul 21, 2021 1:52 pm

QualityStocksNewsBreaks – BAND Royalty Tapping ‘Secret Hidden World of Investing’

BAND Royalty, an enterprising music technology company, has emerged as a revolutionary new player in the non-fungible token (“NFT”) market. The company has applied its experience in music industry investments to the digital art collectibles arena in order to create a new type of best-of-both-worlds product. The product combines NFT art with a potential DeFi project that allows people to share in music royalties. BAND Royalty’s first series of 3,000 NFTs made available for sale to the public on May 15 includes royalties from music catalog selections featuring artists such as Justin Timberlake, Jay-Z, Beyonce and Timbaland. According to a…

WednesdayJul 21, 2021 1:38 pm

QualityStocksNewsBreaks– Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) Advocates for Temperature-Fighting Cannabis to Beat Record Heat

Chalice Brands (CSE: CHAL) (OTCQB: CHALF), a consumer-driven cannabis company in the medicinal and recreational marijuana market segments, is building a strong presence in Oregon. This presence allows interested Oregonians to test the cannabis cooling theory captured in a Chalice magazine article titled “Cannabis Is Cool.” The theory states that: “Cannabinoids, compounds found in cannabis, can interact with the hypothalamus and endocannabinoid system and subsequently impact temperature regulation while also occupying the vanilloid receptor family (TRPA-1, TRPM8, etc.). . . . Thanks to our interest in cannabis, we know the vanilloid receptors alter our perception of heat and pain and,…

WednesdayJul 21, 2021 1:26 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Moving Psychedelic Therapeutics Field Forward Through Partnership

Cybin (NEO: CYBN) (OTCQB: CLXPF), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, is sponsoring research to see if psychedelic medicine, when used with EMBARK’s supportive therapy, can help clinicians recover from COVID-related distress. The recently launched EMBARK is a groundbreaking psychotherapy model that integrates leading clinical approaches to promote supportive healing with psychedelic medicine. Cybin has co-sponsored the study — which will be led by Dr. Anthony Back, a recognized leader in the fields of palliative care and oncology — in a strategic collaboration with the University of Washington. The study will examine treating…

Site Search

Company Search

Category: Stock Spotlight